10/27/2014 - 9:52am

Rx Response moved to alert status in response to the concern about Ebola in the United States.

10/24/2014 - 11:26am

In the wake of an Oct. 21 blogpost on Health Affairs, “The $500 Billion Medicare Slowdown: A Story About Part D,” Ralph Neas, president and CEO of the Generic Pharmacuetical Association, issued the following statement.

10/24/2014 - 8:57am

Pfizer on Thursday announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules.

10/23/2014 - 2:26pm

The U.S. healthcare system must address the problem of patients not picking up newly-prescribed medicines, according to a NEHI white paper.

10/23/2014 - 2:08pm

The Center for Healthcare Supply Chain Research and the American Association of Colleges of Pharmacy are partnering to provide the nation’s schools of pharmacy a supply chain educational tool surrounding the distribution of specialty pharmaceuticals. 

10/23/2014 - 1:59pm

GlaxoSmithKline expects to have its Ebola vaccine available by year's end.

10/23/2014 - 1:46pm

Actavis on Thursday confirmed that the United States Court of Appeals for the Federal Circuit has upheld a lower court ruling that found United States Patent No. 7,704,984 (the '984 Patent) to be valid.

10/23/2014 - 12:59pm

The Pharmaceutical Research and Manufacturers of America earlier this week announced that Christina Stow will join the organization as VP communications, effective Oct. 27. 

10/22/2014 - 2:16pm

The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.